BMC Infectious Diseases volume 20, Article number: 122 (2020)
The Original Article was published on 17 January 2020
Correction to: BMC Infectious Diseases (2020) 20:58.
https://doi.org/10.1186/s12879-020-4787-4
After publication of the original article [1], we were notified that an author’s family name has been erroneously spelled. Aditya Chandrokar should be replaced with Aditya Chandorkar.
The original article has been corrected as well.
Rogers et al. Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infectious Diseases (2020) 20:58, doi: https://doi.org/10.1186/s12879-020-4787-4
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rogers, R., Saharia, K., Chandorkar, A. et al. Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infect Dis 20, 122 (2020). https://doi.org/10.1186/s12879-020-4848-8
Published:
DOI: https://doi.org/10.1186/s12879-020-4848-8
